Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG(4) response

BACKGROUND: BM32, a grass pollen allergy vaccine containing four recombinant fusion proteins consisting of hepatitis B-derived PreS and hypoallergenic peptides from the major timothy grass pollen allergens adsorbed on aluminium hydroxide has been shown to be safe and to improve clinical symptoms of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EBioMedicine
Main Authors: Eckl-Dorna, Julia, Weber, Milena, Stanek, Victoria, Linhart, Birgit, Ristl, Robin, Waltl, Eva E., Villazala-Merino, Sergio, Hummel, Andrea, Focke-Tejkl, Margarete, Froeschel, Renate, Neubauer, Angela, Henning, Rainer, Perkmann, Thomas, Valenta, Rudolf, Niederberger, Verena
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Research paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6921329/
https://ncbi.nlm.nih.gov/pubmed/31786130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2019.11.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados